http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE...
FDA Drug Approvals List June 2002 - Drug Approvals for June 2002 Definitions and Notes Original New Drug Applications Original Application # 021316 Approval Date: 26-JUN-02 Trade Name: ALTOCOR Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: AURA LABORATORIES INC Active Ingredient(s): LOVASTATIN OTC/RX Status: RX INDICATION OF USE: For lowering total cholesterol and LDL-C to target levels as...
http://www.fda.gov/cder/foi/label/2002/20326s11s13lbl.pdf 1 NEUTREXIN ® (trimetrexate glucuronate for injection) Black Box WARNINGS NEUTREXIN (TRIMETREXATE GLUCURONATE FOR INJECTION) MUST BE USED WITH CONCURRENT LEUCOVORIN (LEUCOVORIN PROTECTION) TO AVOID POTENTIALLY SERIOUS OR LIFE- THREATENING TOXICITIES (SEE PRECAUTIONS AND DOSAGE AND ADMINISTRATION)Trimetrexate, a 2,4- diaminoquinazoline,...
http://www.fda.gov/cder/foi/label/2002/20326s11s13lbl.pdf page 1
Prescription and OTC Drug Product List 7/1998 Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 7: July 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE - ADD - CALFACTANT TABLET; ORAL - ADD - INJECTABLE; INJECTION BUTALBITAL,ACETAMINOPHEN AND CAFFEINE - ADD - INFASURF PRESERVATIVE FREE - ADD - AB + MIKART 500MG...
Prescription and OTC Drug Product List 2/2000 Prescription and Over-the-Counter Drug Product List - 20th Edition Cumulative Supplement Number 2: February 2000 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE CICLOPIROX TABLET; ORAL CREAM; TOPICAL LORTAB LOPROX - DLT - UCB 325MG;5MG N40099 001 - ADD - + AVENTIS PHARMS 0.77% N18748 001 - DLT - JUN 25, 1997 - ADD -...
Drug Approvals for August 1997 Drug Approvals for August 1997 Definitions and Notes August 1997 Original New Drug Applications Original Application #: 020808 Approval Date: 29-AUG-97 Trade Name: VISIPAQUE Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: NYCOMED INC Active Ingredient(s): IODIXANOL OTC/RX Status: RX Indication(s): Intra-arterial - for visceral intra-arterial digital...
Dana-Farber Cancer Institute provides cancer information on all cancer types: Clinical Trials Home : Cancer Information : National Clinical Trials Cancer Information by Disease What is Cancer? National Clinical Trials Cancer Prevention Screening & Detection Resources on the Web Dictionary of Medical ...
Dana-Farber Cancer Institute provides cancer information on all cancer types: Clinical Trials Home : Cancer Information : National Clinical Trials Cancer Information by Disease What is Cancer? National Clinical Trials Cancer Prevention Screening & Detection Resources on the Web Dictionary of Medical ...
Dana-Farber Cancer Institute provides cancer information on all cancer types: Clinical Trials Home : Cancer Information : National Clinical Trials Cancer Information by Disease What is Cancer? National Clinical Trials Cancer Prevention Screening & Detection Resources on the Web Dictionary of Medical ...
Dana-Farber Cancer Institute provides cancer information on all cancer types: Clinical Trials Home : Cancer Information : National Clinical Trials Cancer Information by Disease What is Cancer? National Clinical Trials Cancer Prevention Screening & Detection Resources on the Web Dictionary of Medical ...
Approved Products_2004.xls Number A pproval Date Trade Name Generic/ Chemical name Indication Company 1 Oct- 82 Humulin Human Insulin Type I Diabetes Lilly / Genentech 2 Oct- 85 Protro pin Human Growth Hormone Hypoptuitary dwarfism Genentech 3 Jun- 86 Intron A Interferon Al pha 2B Hairy Cell Leukemia Schering Plough / Biogen 4 Jun- 86 OKT- 3 Anti CD3 Mab Acute Trans plant Rejection JNJ / OrthoBiotech 5 Jun- 86...
author: Reijer
Approved Products_2004.xls page 1
author: Reijer
June appletter.PDF DESCRIPTION ·The third sentence in the first paragraph was revised to read: "Neutrexin is available as a sterile lyophilized powder in multi dose vials, containing trimetrexate glucuronate equivalent to either 200 mg or 25 mg of trimetrexate without any preservatives or excipients." 2
author: andersonr
June appletter.PDF page 1
author: andersonr
http://www.fda.gov/cder/foi/label/2002/20326s11s13lbl.pdf page 15
http://www.fda.gov/cder/foi/label/2002/20326s11s13lbl.pdf page 12
http://www.fda.gov/cder/foi/label/2002/20326s11s13lbl.pdf page 11
Side Effects DRUG REVIEWS Antiretroviral / Antifungal / Antiviral / Antiparasitic / Antimycobacterial -Usual Dosages- reflect those used for normal renal and hepatic function and no drug interactions -Possible Side Effects- list common adverse reactions ANTIRETROVIRAL AGENTS 1
http://www.hivatis.org/publications/fullist_en.pdf page 6 6 Drug Classification Other Common Name( s) Saquinavir (Soft Gel CapsuleSGC Saquinavir mesylate (Hard Gel Capsule- HGC) Antiretroviral Protease Inhibitor (PI) Fortovase® (SGC) Invirase® (HGC) SQV FDA approved 12/ 07/ 95 Invirase (HGC) for combination use with nucleoside analogues for the treatment ...
